Loomis, Sayles & Company’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $9.62M | Sell |
158,632
-64,612
| -29% | -$3.77M | 0.01% | 359 |
|
|
2025
Q4 | $12M | Buy |
223,244
+44,910
| +25% | +$2.16M | 0.01% | 330 |
|
|
2025
Q3 | $8.04M | Buy |
178,334
+13,928
| +8% | +$650K | 0.01% | 386 |
|
|
2025
Q2 | $7.61M | Buy |
164,406
+69,966
| +74% | +$3.43M | 0.01% | 401 |
|
|
2025
Q1 | $5.76M | Sell |
94,440
-150,728
| -61% | -$8.79M | 0.01% | 411 |
|
|
2024
Q4 | $13.9M | Sell |
245,168
-32,431
| -12% | -$1.81M | 0.02% | 320 |
|
|
2024
Q3 | $14.4M | Buy |
277,599
+62,602
| +29% | +$2.94M | 0.02% | 306 |
|
|
2024
Q2 | $8.93M | Buy |
214,997
+68,277
| +47% | +$3.06M | 0.01% | 376 |
|
|
2024
Q1 | $7.96M | Buy |
146,720
+40,778
| +38% | +$2.08M | 0.01% | 374 |
|
|
2023
Q4 | $5.44M | Buy |
105,942
+49,458
| +88% | +$2.6M | 0.01% | 393 |
|
|
2023
Q3 | $3.28M | Sell |
56,484
-5,087
| -8% | -$312K | 0.01% | 415 |
|
|
2023
Q2 | $3.94M | Buy |
61,571
+14,919
| +32% | +$1M | 0.01% | 408 |
|
|
2023
Q1 | $3.23M | Sell |
46,652
-8,171
| -15% | -$576K | 0.01% | 422 |
|
|
2022
Q4 | $3.94M | Buy |
54,823
+5,378
| +11% | +$406K | 0.01% | 385 |
|
|
2022
Q3 | $3.52M | Sell |
49,445
-203,215
| -80% | -$14.7M | 0.01% | 383 |
|
|
2022
Q2 | $19.5M | Sell |
252,660
-156,371
| -38% | -$11.9M | 0.04% | 252 |
|
|
2022
Q1 | $29.9M | Sell |
409,031
-171,403
| -30% | -$11.5M | 0.04% | 232 |
|
|
2021
Q4 | $36.2M | Buy |
580,434
+14,204
| +3% | +$833K | 0.04% | 228 |
|
|
2021
Q3 | $33.5M | Sell |
566,230
-1,310,346
| -70% | -$86.3M | 0.04% | 233 |
|
|
2021
Q2 | $125M | Sell |
1,876,576
-3,409,763
| -65% | -$222M | 0.15% | 70 |
|
|
2021
Q1 | $334M | Sell |
5,286,339
-6,177,770
| -54% | -$384M | 0.43% | 35 |
|
|
2020
Q4 | $711M | Sell |
11,464,109
-1,922,942
| -14% | -$118M | 0.94% | 30 |
|
|
2020
Q3 | $807M | Sell |
13,387,051
-189,768
| -1% | -$11.4M | 1.17% | 27 |
|
|
2020
Q2 | $798M | Sell |
13,576,819
-12,187
| -0.1% | -$729K | 1.28% | 27 |
|
|
2020
Q1 | $757M | Sell |
13,589,006
-168,113
| -1% | -$10.3M | 1.56% | 21 |
|
|
2019
Q4 | $883M | Sell |
13,757,119
-586,460
| -4% | -$33.6M | 1.5% | 25 |
|
|
2019
Q3 | $727M | Buy |
14,343,579
+22,615
| +0.2% | +$1.06M | 1.4% | 26 |
|
|
2019
Q2 | $649M | Buy |
14,320,964
+1,850,195
| +15% | +$86.2M | 1.21% | 29 |
|
|
2019
Q1 | $595M | Buy |
12,470,769
+1,639,468
| +15% | +$81.7M | 1.17% | 32 |
|
|
2018
Q4 | $563M | Buy |
10,831,301
+856,802
| +9% | +$46M | 1.33% | 29 |
|
|
2018
Q3 | $619M | Sell |
9,974,499
-3,428,625
| -26% | -$203M | 1.21% | 29 |
|
|
2018
Q2 | $742M | Sell |
13,403,124
-64,206
| -0.5% | -$3.47M | 1.5% | 23 |
|
|
2018
Q1 | $852M | Sell |
13,467,330
-46,287
| -0.3% | -$2.98M | 1.81% | 20 |
|
|
2017
Q4 | $828M | Sell |
13,513,617
-74,440
| -0.5% | -$4.66M | 1.72% | 20 |
|
|
2017
Q3 | $866M | Buy |
13,588,057
+369,832
| +3% | +$21.6M | 1.89% | 18 |
|
|
2017
Q2 | $737M | Buy |
13,218,225
+65,794
| +0.5% | +$3.58M | 1.73% | 20 |
|
|
2017
Q1 | $715M | Sell |
13,152,431
-495,041
| -4% | -$27.2M | 1.78% | 17 |
|
|
2016
Q4 | $798M | Buy |
13,647,472
+33,572
| +0.2% | +$1.84M | 1.96% | 11 |
|
|
2016
Q3 | $734M | Buy |
13,613,900
+268,989
| +2% | +$17.3M | 1.86% | 13 |
|
|
2016
Q2 | $982M | Sell |
13,344,911
-128,820
| -1% | -$9.1M | 2.67% | 7 |
|
|
2016
Q1 | $861M | Sell |
13,473,731
-1,496
| -0% | -$94.3K | 2.44% | 8 |
|
|
2015
Q4 | $927M | Buy |
13,475,227
+69,462
| +0.5% | +$4.59M | 2.61% | 5 |
|
|
2015
Q3 | $794M | Buy |
13,405,765
+3,057
| +0% | +$194K | 2.35% | 8 |
|
|
2015
Q2 | $892M | Buy |
13,402,708
+247,131
| +2% | +$16.3M | 2.44% | 5 |
|
|
2015
Q1 | $849M | Sell |
13,155,577
-899,343
| -6% | -$56.3M | 2.35% | 4 |
|
|
2014
Q4 | $830M | Sell |
14,054,920
-894,966
| -6% | -$50.5M | 2.3% | 4 |
|
|
2014
Q3 | $765M | Sell |
14,949,886
-49,905
| -0.3% | -$2.49M | 2.24% | 4 |
|
|
2014
Q2 | $728M | Buy |
14,999,791
+318,767
| +2% | +$15.7M | 2.07% | 5 |
|
|
2014
Q1 | $763M | Buy |
14,681,024
+16,574
| +0.1% | +$882K | 2.16% | 5 |
|
|
2013
Q4 | $779M | Sell |
14,664,450
-153,537
| -1% | -$7.82M | 2.34% | 5 |
|
|
2013
Q3 | $686M | Sell |
14,817,987
-1,652
| -0% | -$72.5K | 2.22% | 5 |
|
|
2013
Q2 | $662K | Buy |
+14,819,639
| New | +$643M | 2.36% | 5 |
|
Other funds holding BMY
VCM
VPM
Loomis, Sayles & Company's BMY Position: Q1 2026 in Review
Loomis, Sayles & Company reduced its Bristol-Myers Squibb (BMY) stake by 29% in Q1 2026, selling an estimated $3.77M and leaving 158,632 shares worth $9.62M. The position accounts for 0.01% of the portfolio, ranked #359.
Loomis, Sayles & Company first reported a position in BMY in Q2 2013 and has held it in 52 quarters since. The position peaked at $982M in Q2 2016. 2,519 funds tracked by Wall St. Rank hold BMY as of Q1 2026.
- Loomis, Sayles & Company held 158,632 shares of Bristol-Myers Squibb worth $9.62M as of Q1 2026.
- Loomis, Sayles & Company sold 64,612 Bristol-Myers Squibb shares in Q1 2026, an estimated $3.77M.
- Bristol-Myers Squibb made up 0.01% of Loomis, Sayles & Company's portfolio in Q1 2026, its #359 holding.
- Loomis, Sayles & Company first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 52 quarters since.
- Loomis, Sayles & Company's Bristol-Myers Squibb position peaked at $982M in Q2 2016.
- 2,519 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.
Based on Loomis, Sayles & Company's 13F filing for Q1 2026, filed 14 May 2026.